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Edited by Vladimir SkulachevAbstract Treatment of IMR-90 human diploid ﬁbroblasts with
a sublethal concentration of H2O2 induces premature senescence.
We investigated the protein abundance, subcellular localization
and involvement of caveolin 1 in premature senescence. Caveolin
1 is a scaﬀolding protein able to concentrate and organize signal-
ing molecules within the caveolae membrane domains. We report
the ﬁrst evidence of increased nuclear and cytoplasmic localiza-
tion of caveolin 1 during establishment of H2O2-induced prema-
ture senescence. Moreover, we demonstrate that phosphorylation
of caveolin 1 during treatment with H2O2 is dependent on p38a
mitogen-activated protein kinase.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Senescent human diploid ﬁbroblasts (HDFs) obtained after
serial subcultivation display typically enlarged cell shape,
senescence associated b-galactosidase activity (SA b-gal),
changes in the expression level of many genes and irreversible
growth arrested [1–4]. HDFs treated with sublethal concentra-
tions of hydrogen peroxide (H2O2) or tert-butylhydroperoxide
(t-BHP) display markers of senescence within two or three
days after the stress [5–10]. This is stress-induced premature
senescence (SIPS) [11].
Caveolin 1 (Cav1) is the principal structural component of
caveolae membrane domains and is a scaﬀolding protein able
to concentrate and organize signaling molecules within the
caveolae [12,13].Abbreviations: FBS, fetal bovine serum; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; HDF, human diploid ﬁbroblast; IgG,
immunoglobulin G; MAPK, mitogen-activated kinase; MEM, mini-
mum essential medium; mRNA, messenger ribonucleic acid; MTT, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction
assay; PBS, phosphate buﬀer saline; RT-PCR, reverse transcriptase-
polymerase chain reaction; S.D., standard deviation; SA b-gal activity,
senescence associated-b galactosidase activity; siRNA, small interfer-
ing RNA; TGF-b1, transforming growth factor-b1
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doi:10.1016/j.febslet.2008.04.026Both N- and C-terminal domains of Cav1 face the cytoplasm
and are accessible for interactions with cytoplasmically ori-
ented molecules [14]. Cav1 mediates the inhibition of Erk
and PI3K proteins in NIH3T3 ﬁbroblasts under cell detach-
ment [15] or induces Akt activation in mesangial human cells
in presence of H2O2 [16,17].
Overexpression of Cav1 induces premature cellular senes-
cence in primary cultures of murine ﬁbroblasts [18]. In
NIH3T3 murine ﬁbroblasts and in endothelial cells treated
with H2O2, p38
MAPK is involved in the phosphorylation of
Cav1 [19,20].
We show herein that Cav1 abundance is increased in cyto-
plasm and nucleus of IMR-90 fetal lung HDFs in H2O2-in-
duced premature senescence. We used small interfering RNA
(siRNA) to down-regulate Cav1 in order to test whether
Cav1 is involved in premature senescence. siRNA were used
to down-regulate p38aMAPK and to study its role in the phos-
phorylation of Cav1 observed during treatment with H2O2.2. Materials and methods
2.1. Cell culture, stress and stimulation
IMR-90 human fetal lung diploid ﬁbroblasts (HDFs) were grown in
minimum essential medium (MEM) (Gibco, UK) supplemented with
10% fetal bovine serum (FBS) (Gibco). IMR-90 HDFs at about 50%
of in vitro proliferative life span (27 population doublings) were seeded
at a density of 24 · 103 cells/cm2. One day later, cells were treated for 1
or 2 h with 150 lM of H2O2 (Merck, Germany) diluted in
MEM + 10% FBS. A 2 h incubation with H2O2 represents a sublethal
treatment [6,21–23]. Controls cells were incubated in culture medium
alone. After treatment, IMR-90 HDFs were washed twice with cold
phosphate buﬀer saline pH 7.4 (10 mM phosphate, 0.9% NaCl)
(PBS) and incubated with fresh MEM + 10% FBS. The appearance
of biomarkers of senescence was checked (decrease of the proliferative
potential and increase in SA b-gal-staining) [6,21,22] from the 2nd to
the 3rd day after treatment.
2.2. RT-real time PCR
RNA extraction, choice of the sequences of primers and RT-real
time polymerase chain reaction (PCR) was performed as detailed in
[22]. Sequences of the primers can be found in Table 1A. The abun-
dance of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mes-
senger ribonucleic acid (mRNA) was used as a reference for semi-
quantiﬁcation with the classical ‘‘DDCT method’’ [24].
2.3. Western blots
Extraction of total proteins was performed as detailed in [22].
Extraction of nuclear proteins: cells were washed with PBS, scraped
in hypotonic lysis buﬀer (HEPES 10 mM, pH 7.9, KCl 10 mM, EDTAblished by Elsevier B.V. All rights reserved.
Table 1A






Forward 5 0-ACCCACTCCTCCACCTTTGAC-3 0
Reverse 5 0-GTCCACCACCCTGTTGCTGTA-3 0
Table 1B
List of the four sense and antisense sequences of siRNA targeting Cav1
or p38aMAPK
siGENOME SMART pool M-003467-01, Human Cav1, NM_001753
Sense sequence 1 CUAAACACCUCAACGAUGAUU
Antisense sequence 1 50-PUCAUCGUUGAGGUGUUUAGUU
Sense sequence 2 GCAGUUGUACCAUGCAUUAUU
Antisense sequence 2 50-PUAAUGCAUGGUACAACUGCUU
Sense sequence 3 AUUAAGAGCUUCCUGAUUGUU
Antisense sequence 3 50-PCAAUCAGGAAGCUCUUAAUUU
Sense sequence 4 GCAAAUACGUAGACUCGGAUU
Antisense sequence 4 50-PUCCGAGUCUACGUAUUUGCUU
siGENOME SMART pool M-003512-05, Human MAPK14
(p38aMAPK), NM_001315
Sense sequence 1 CAAGGUCUCUGGAGGAAUUUU
Antisense sequence 1 50-PAAUUCCUCCAGAGACCUUGUU
Sense sequence 2 GUCAGAAGCUUACAGAUGAUU
Antisense sequence 2 50-PUCAUCUGUAAGCUUCUGACUU
Sense sequence 3 CGGCUUAUCUCAUUAACAGUU
Antisense sequence 3 50-PCUGUUAAUGAGAUAAGCGGUU
Sense sequence 4 GUCCAUCAUUCAUGCGAAAUU
Antisense sequence 4 50-PUUUCGCAUGAAUGAUGGACUU
1686 A. Chre´tien et al. / FEBS Letters 582 (2008) 1685–16920.1 mM, EGTA 0.1 mM (all from Merck), nonidet P-40 0.5% (Sigma–
Aldrich, USA), dithiothreitol 1 mM (Amersham GE Healthcare, Swe-
den), and protease inhibitor), passed through a loose ﬁtting Dounce
homogenizer, and centrifuged at 3000 rpm for 3 min. Pellet (nuclear
fraction) was washed with hypotonic lysis buﬀer before resuspension
in the same buﬀer and sonication.
Western blots were performed as described in [22] using these anti-
bodies: anti-caveolin1 mouse immunoglobulin G (IgG), anti-phos-
pho-caveolin1 mouse IgG (BD Transduction Laboratories, Belgium),
anti-caveolin1 rabbit IgG, anti-phospho-Akt (Ser 473) rabbit IgG,
anti-Akt rabbit IgG, anti-phospho-Erk1/2 (Thr 202/Tyr 204) rabbit
IgG, anti-Erk1 mouse IgG, anti-Erk2 mouse IgG, anti-phospho-L-
CaD (Ser 789) rabbit IgG (Cell Signaling, USA), anti-Histone H1
mouse IgG, anti-p21 mouse IgG (Santa Cruz Biotechnology, USA),
anti-a-tubulin mouse IgG (Clone B-5-1-2, Sigma–Aldrich) and horse-
radish peroxidase-linked secondary antibodies (anti-mouse antibodies:
Amersham GE Healthcare). a-Tubulin and Histone H1 were used as
reference protein for respectively, total and nuclear cell lysates analy-
sis. Triplicates were performed.
2.4. Confocal microscopy
Cells were seeded at 20000 cells/cm2 in MEM + 10% FBS on a glass
cover slide. One day later, cells were ﬁxed with paraformaldehyde 3%
(Sigma–Aldrich). Cells were permeabilized with 1% Triton X-100. Spe-
ciﬁc mouse antibody Cav1 was added followed by the speciﬁc Alexa
Fluor 488 anti-mouse conjugate antibody (Molecular Probes, USA).
To visualize the nucleus, cells were incubated with TO-PRO-3 (ICN,
USA). The glass cover slides were mounted in Mowiol (Sigma) and ob-
served with a TCS confocal microscope (Leica, Germany) at constant
multiplier. Triplicates were performed.2.5. siRNA transfection
The siGENOME SMARTpool siRNA reagent M-003467-01 or M-
003512-05 from Dharmacon (Belgium) were used to down-regulate
the expression of Cav1 and p38aMAPK, respectively. The sequences
of siRNA are provided (Table 1B) and are guaranteed by the manufac-
turer. Non-targeting oligoribonucleotides (OR-0030-neg, Eurogentec,
Belgium) were used as negative control. IMR-90 HDFs were seeded
at half-conﬂuency (20 · 103 cells/cm2). One day later, the cells were
transfected for 36 h, starting at day 3 before treatment with H2O2,
with siRNA at 50 nM in MEMmedium using Dharmafect transfection
reagent. Cells were plated at day 1 before treatment with H2O2
(Fig. 2A). Cell viability was evaluated using the classical 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction assay
(MTT) (Sigma–Aldrich, Germany) [25].3. Results
3.1. Increased abundance of total and phosphorylated Cav1 after
treatment of IMR-90 HDFs with H2O2 at sublethal
concentration
IMR-90 HDFs were treated for 2 h with H2O2 at 150 lM.
This represents a sublethal treatment as shown earlier
[5,6,21]. After the treatment with H2O2 at day 0, the cells
exhibited a decrease of proliferative potential from day 2 to
3 and an increase in proportion of cells stained positive for
SA b-gal at 3 days after the treatment, indicating that the cells
underwent senescence [1,6,21,22] (data not shown).
No diﬀerence for Cav1 mRNA abundance could be detected
by RT-real time PCR from 4 h to 3 days after the 2 h-treatment
with H2O2, except a slight decrease at one day after treatment
(Fig. 1A). As for Cav1 total protein abundance, Western blots
showed an increase from 1 day to 3 days after treatment with
H2O2, compared to non-treated controls (Fig. 1B). From day
1 to day 3 after the treatment with H2O2, the phospho-Cav1
abundance increased in parallel to the total abundance of
Cav1. Independent of these variations, H2O2 induced the phos-
phorylation of Cav1 after 1 and 2 h of treatment and for 8 h
after treatment withH2O2, comparedwith non-treated controls.
3.2. Nuclear localization of Cav1 in IMR-90 HDFs
Cav1 is often described as a plasma membrane protein [26].
We analyzed the subcellular localization of Cav1 at day 1 and
2 after H2O2 treatment. Surprisingly, the analysis of immuno-
labeled Cav1 showed a cytoplasmic and a nuclear localization
in IMR-90 HDFs (Fig. 1C). An increase in the protein abun-
dance was also observed, conﬁrming the Western blots analysis
presented at Fig. 1B.
To conﬁrm the localization of Cav1, we analyzed cytoplasmic
and nuclear extracts by Western blot. Cav1 was found in both
cytoplasm and in nucleus (Fig. 1D). H2O2 treatment increased
the abundance of Cav1 in the nuclear and cytoplasmic extracts.
a-Tubulin was used as cytoplasmic protein marker and was ab-
sent in the puriﬁed nuclear extracts. Histone H1 was detected as
nuclearmarker andwas not detected in the cytoplasmic extracts.
These results were obtained with two diﬀerent anti-Cav1 speciﬁc
antibodies directed towards diﬀerent antigenic areas of Cav1 se-
quence. To our knowledge, this is the ﬁrst time that nuclear
localization of Cav1 is reported in human ﬁbroblasts. The siR-
NA analysis presented beneath further conﬁrmed these results.
3.3. Down-regulation of Cav1 expression
Since Cav1 is overexpressed after treatment with H2O2 and
thus potentially regulates premature senescence, we used spe-
Fig. 1. Eﬀect of a treatment of IMR-90 HDFs with H2O2 at 150 lM for 2 h on Cav1 mRNA abundance, protein abundance, and subcellular
localization. (A) Cav1 mRNA abundance at increasing times after treatment with H2O2. The abundance of GAPDH mRNA was used as a reference.
The results are expressed in percentages of control cells before treatment and are given as the mean ± S.D. of three independent experiments. As for
statistical analysis, a Students t-test has been performed. NS, non signiﬁcant (P < 0.05); *, 0.05 > P > 0.01. (B) Phospho-Cav1 and Cav1 protein
abundance at increasing times after treatment with H2O2. a-Tubulin protein abundance was used as loading control. Analyses were performed in
three independent experiments. Representative results are shown. (C) Analysis of subcellular localization of Cav1. IMR 90-HDFs were treated for
2 h with H2O2 at 150 lM and were ﬁxed 3 days later and the Cav1 subcellular localization was detected using a speciﬁc antibody (green). The nuclei
were stained with TO-PRO-3 (blue). (D) Analysis of Cav1 cytoplasmic and nuclear protein abundance. IMR 90-HDFs were treated for 2 h with
H2O2 at 150 lM. Total proteins or nuclear proteins were extracted at 1 day after the treatment from control and treated cells. a-Tubulin or histone
H1 were used as loading control, respectively for cytoplasmic or nuclear extracts. Analyses were performed in three independent experiments.
Representative results are shown.
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potential eﬀects of this down-regulation on H2O2-induced pre-
mature senescence. The experimental procedure is depicted in
Fig. 2A. Cav1 mRNA abundance decreased by 90.6 ± 5.9%
or by 96.8 ± 5.5% compared to cells before the transfection
at 2 days or 4 days after the beginning of transfection (day
1 or day 1 in Fig. 2A) (Fig. 2B). However, 6 days after the
beginning of the transfection (day 3 in Fig. 2A) were necessary
before Cav1 protein vanished (Fig. 2C). Transfection of IMR-
90 HDFs with Cav1 siRNA did not signiﬁcantly reduce the cellnumber at 6 days after the beginning of the transfection (day 4
in Fig. 2A), which suggests absence of cell death after transfec-
tion (Fig. 2D). Then, we treated cells with H2O2 at day 3 after
transfection. In presence of Cav1 siRNA, no Cav1 protein
could be detected neither in cytoplasmic nor in nuclear extracts
after treatment with H2O2 or not (Fig. 3A). These results were
obtained with two speciﬁc antibodies anti-Cav1 directed to-
wards diﬀerent antigenic areas of Cav1 sequence. These obser-
vations after down-regulation of Cav1 with siRNA conﬁrmed
that the protein detected in the nuclear extracts is indeed Cav1.
B Cav1 mRNA abundance (day -2) C Cav1 protein abundance  
Neg siRNA + - + - + - 
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Fig. 2. Speciﬁc silencing of Cav1 siRNA and eﬀect of siRNA transfection on the viability of IMR-90 HDFs. (A) Schematic representation of the
experimental schedule for IMR-90 HDFs transfection with siRNA and treatment with H2O2. (B) mRNA abundance of Cav1 in IMR-90 HDFs
transfected with 50 nM siRNAs targeting Cav1 or with negative siRNA. IMR-90 HDFs incubated with Dharmafect (Dharm) or with medium alone
(‘‘medium’’) were also analyzed. Total RNA was extracted at 1 day after transfection. GAPDH mRNA abundance was used as a reference. The
results are expressed in percentages of the values found in control ‘‘medium’’ and are presented as the means ± S.D. from three independent
experiments. As for statistical analysis, a Students t-test was performed to compare values with the control medium: +++, P < 0.001. (C) Western
blot analysis of IMR-90 HDFs cell lysates transfected with 50 nM siRNAs targeting Cav1 or with negative siRNA. Proteins were extracted at day
1, 1 or 3. IMR-90 HDFs incubated with Dharmafect (Dharm) were also analyzed at day 3. a-Tubulin protein abundance was used as loading
control. Analyses were performed in three independent experiments. Representative results are shown. (D) IMR-90 HDFs were transfected with
indicated siRNA, incubated with Dharmafect (Dharm) or incubated with medium alone for 36 h. MTT assay was performed before transfection at
day 3 and at day 4. The results are expressed in percentages of the values found in control cells before transfection (day 3) and are given as the
means ± S.D. from three independent experiments. Statistical analysis was performed with the Students t-tests either to compare the values with the
control before transfection (day 3): +, 0.05 > P > 0.01; ++, 0.01 > P > 0.001 or to compare values with the controls transfection at day 4: NS, non-
signiﬁcant (P > 0.05).
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Cav1 was described to aﬀect the morphology and growth ar-
rest of NIH3T3 murine ﬁbroblasts treated with H2O2 [18].
Since Cav1 total abundance and phospho-Cav1 abundance in-
creased after treatment with H2O2, we investigated whether
Cav1 was involved in premature senescence in IMR-90 HDFs.
At 3 days after treatment with H2O2 at sublethal concentra-
tion, IMR-90 HDFs showed a senescent-like morphology
(Fig. 3B) [5,6,27]. Cav1 down-regulation did not block thismorphological change (Fig. 3B) nor the actin and paxillin dis-
tribution normally seen after the treatment (data not shown)
[27].
Cav1 down-regulation did not alter the sharp decrease in
[3H] thymidine incorporation into DNA, nor the increase in
p21WAF1 and TGF-b1 mRNA, and in the proportion of SA
b-gal positive HDFs, all normally observed after treatment
with H2O2 at sublethal concentration. The representative re-
sults are detailed in Table 2.
ATime Day 1
H2O2 - + - + - + - +
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Fig. 3. (A) Western blot analysis of total or nuclear lysates of IMR-90 HDFs transfected with 50 nM siRNAs targeting Cav1 or incubated with
medium alone. Proteins were extracted at day 1 and a-tubulin or histone H1 were used as loading control respectively for total cell or nuclear
extracts. Analyses were performed in three independent experiments. Representative results are shown. (B) Morphology of IMR-90 HDFs before
treatment with H2O2 (day 0) and at day 3 after the 2 h-treatment with H2O2. IMR-90 HDFs were transfected with indicated siRNA for 36 h.
Representative micrographs of IMR-90 HDFs in phase-contrast microscopy are shown.
Table 2
Eﬀect of Cav1 down-regulation on markers of premature senescence induced by H2O2
‘‘Medium’’ Dharm siRNA neg siRNA Cav1
A [3H] thymidine incorporation (% of control) 25 ± 12 21 ± 7 21 ± 5 23 ± 8
B SA b-gal activity (fold-increase of positive cells) (Ctrl: 10 ± 2.9) 5.2 ± 2.6 5.1 ± 1.5 3.5 ± 0.5 3.2 ± 0.0
C p21WAF1 mRNA abundance (fold-increase) 10.3 ± 0.8 4.7 ± 0.1 4.2 ± 0.1 7.2 ± 2.7
D TGF-b1 mRNA abundance (fold increase) 2.3 ± 0.8 2.2 ± 0.1 2.2 ± 0.1 1.9 ± 0.5
At day 3, IMR-90 HDFs were transfected with indicated siRNA, incubated with Dharmafect (Dharm) or with medium alone (‘‘medium’’) for 36 h.
Cells were treated with H2O2 at 150 lM for 2 h at day 0.
(A) Estimation of proliferative potential of IMR-90 HDFs: incorporation of [3H] thymidine (1 lCi/ml) into DNA was measured between the day 2
and 3. Data were reported to protein abundance obtained before incubation with [3H] thymidine. Then, the results are reported to control cells
(‘‘medium’’). Percentages between control and treated cells are given as the means ± S.D. from three independent experiments.
(B) Proportion of cells positive for SA b-gal activity was determined at day 3. The ratios between control and treated cells are given as the
means ± S.D. from three independent experiments.
(C and D) p21WAF1 and TGF-b1 mRNA abundance estimated at day 1. The abundance of GAPDH mRNA was used as reference. The results are
reported to the control cells before the transfection and ratios between control and treated cells are given as the means ± S.D. from three independent
experiments.
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the tyrosine phosphorylation of Cav1
p38MAPK is phosphorylated during treatment of IMR-90
with H2O2 [21,22]. In murine NIH3T3 ﬁbroblasts, tyrosine
phosphorylation of Cav1 after treatment with H2O2 at 5 mM
for 20 min is reversible and dependent on p38MAPK and c-
Src kinase [19]. We investigated the involvement of p38aMAPK
protein in the abundance of phosphorylated Cav1 during treat-
ment of IMR-90 HDFs with sublethal concentration of H2O2
(Fig. 4A). p38aMAPK down-regulation decreased the abun-
dance of phospho-Cav1 without change in the total amount
of Cav1.In other in vitro human models, Cav1 can induce the phos-
phorylation of Akt and Erk [15]. Thus, we checked whether
phosphorylation of Akt and Erk is observed after sublethal
treatment of IMR-90 HDFs with H2O2. The phosphorylation
of Erk and Akt increased from 8 h to 3 days after treatment
with H2O2 compared to control cells, without change in the to-
tal abundance of these proteins (Fig. 4B). Cav1 siRNA did not
alter the change of abundance of phospho-Akt and phospho-
Erk after treatment with H2O2 (data not shown). In presence
of Cav1 siRNA, the abundance of p21WAF1 was still sharply
increased at 1 day after treatment with H2O2 (Fig. 4C). This is
interesting since it has been described that overexpression of
A Effect of p38αMAPK siRNA on total and phospho-Cav1
abundance after 1 h of treatment with H2O2
H2O2 - + - + - + - +
p38MAPK siRNA - - - - - - + +
neg siRNA - - - - + + - -
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p-Akt (Ser 473)
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p-Erk (Thr 202/Tyr 204)
Erk
α-tubulin
C Effect of Cav1 siRNA on p21WAF-1 protein abundance at
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Time after beginning of 2 h-treatment with
H2O2 in hours (h) and days (d)
Fig. 4. (A) Eﬀect of p38aMAPK down-regulation with siRNA on phospho-Cav1 and Cav1 protein abundance during treatment with H2O2. IMR-90
HDFs were transfected with indicated siRNA, incubated with Dharmafect (Dharm) or with medium alone. Proteins were extracted after a 1 h-
treatment with H2O2. (B) Eﬀect of a treatment of IMR-90 HDFs with H2O2 at 150 lM for 2 h on total and phosphorylated Akt and Erk protein
abundance at increasing times after treatment with H2O2. a-Tubulin protein abundance was used as loading control. Analyses were performed in
three independent experiments. Representative results are shown. (C) Eﬀect of Cav1 down-regulation with siRNA on p21WAF-1 protein abundance
after treatment with H2O2. IMR-90 HDFs were transfected with indicated siRNAs, incubated with Dharmafect (Dharm) or with medium alone.
Proteins were extracted at day 1 after the 2 h-treatment with H2O2. a-Tubulin protein abundance was used as a loading control. Analyses were
performed in three independent experiments, representative results are shown.
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blasts, which is reduced in presence of Cav1 anti-sense oligonu-
cleotides [18].4. Discussion
Treatment of IMR-90 HDFs with a sublethal concentration
of H2O2 induces premature senescence. p38
MAPK is activated
in IMR-90 HDFs by a sublethal concentration of H2O2 [6].
Nothing has been published so far as for a role of Cav1 in pre-
mature senescence of normal HDFs. We showed that theabundance of phosphorylated Cav1 is increased during treat-
ment with H2O2 and for at least 3 days after treatment with
H2O2 while total Cav1 abundance is increased from 1 to 3 days
after treatment. In HDFs, in contrast to NIH3T3 murine cells,
Cav1 did not seem to regulate cell survival, irreversible growth
arrest, increase of percentage of SA-b gal positive cells, in-
crease abundance of p21WAF1 mRNA and protein, increased
of transforming growth factor-b1 (TGF-b1) mRNA abun-
dance, activation of Erk1/2 and Akt, nor senescent morpho-
genesis observed in H2O2-induced premature senescence. We
demonstrated that p38aMAPK is involved in the phosphoryla-
tion of Cav1 after a 1 h of treatment with H2O2. Other studies
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reversible upon H2O2 withdrawal. In contrast, we showed that
the phosphorylation of Cav1 is sustained after the 2 h-treat-
ment of IMR-90 HDFs with H2O2. Even if Cav1 is not in-
creased in short times after the H2O2 treatment, the
phosphorylation status represent an important changes that
could allow this protein to be involved in the activation or
inhibition of numerous mechanisms occurring after this treat-
ment.
The major ﬁnding of this study is that Cav1 can be localized
in the nucleus of HDFs as evidence by immunoﬂuorescence,
Western blot, cells fractionation and siRNA experiments. We
did not ﬁnd a putative nuclear localization signal in the
Cav1 sequence. However, it has already been demonstrated
that Cav1 can be localized in the nucleus of ovarian carcinoma
cells in association with nuclear matrix and chromatin, as well
as in endothelial cells in association with receptors internalized
through caveolae-mediated endocytosis [28–30]. In ovarian
carcinoma cells, Cav1 appears to bind promoter sequences of
genes required for proliferation, such as cyclin D1 and to neg-
atively regulate the transcription of cyclin D1 [28]. However,
cyclin D1 mRNA increases in replicative senescence and in
UVB-induced premature senescence of HDFs [31–34]. Cav1
could regulate the transcription of others genes in IMR-90
HDFs. It has been hypothesized that soluble Cav1 embedded
in a lipid particle can enter the cytoplasm [35]. Cav1 charged
with cholesterol and detached from caveolae might translocate
to the nucleus simply by diﬀusion or in association with a
chaperone protein. Indeed, the Cav1 carboxy-terminal peptide
(aa 135–150) shows sequence similarity to the third helix of the
homeodomain consensus sequence, such as transcription fac-
tors HOXA-5, possibly allowing to through all cell membranes
[36,37]. Alternatively, Cav1 might be retro-transported to the
nucleus through association with vesicles or lipid droplets
moving along microtubules toward their minus-ends driven
by the dynein molecular motor [38].
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